Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence Drawing on insights from over 2,000 librarians representing academic, national and public… CISION PRNewswireOctober 30, 2025
Press Release ARDY FERGUSON WINS ESTEEMED S.PELLEGRINO YOUNG CHEF ACADEMY AWARD 2025 The dish, ‘Archipelago Celebration’ from Asia takes the crown and will help… CISION PRNewswireOctober 30, 2025
Press Release Futurise Unveils 2024 Impact Report: Shaping Tomorrow's Regulatory Landscape CYBERJAYA, Malaysia, Oct. 30, 2025 /PRNewswire/ — Futurise Sdn. Bhd., a company… CISION PRNewswireOctober 30, 2025
Press Release Cabos de Timor-Leste, E.P. and Telin Sign MoU to Strengthen Bilateral Collaboration on Digital Infrastructure Development JAKARTA, Indonesia, Oct. 30, 2025 /PRNewswire/ — Cabos de Timor-Leste, E.P. (CTL) and… CISION PRNewswireOctober 30, 2025
Press Release Thai Specialty Oil Leader Targets Philippine Power Sector as Grid Modernization Drives PHP 900 Billion Infrastructure Boom MANILA, Philippines, Oct. 30, 2025 /PRNewswire/ — As the National Grid Corporation… CISION PRNewswireOctober 30, 2025
Press Release Niutech Secures Another $14M Repeat Order in Europe for High-End Pyrolysis Equipment, Fueling EU's Circular Transition JINAN, China, Oct. 30, 2025 /PRNewswire/ — Recently, Niutech Environment Technology Corporation (Abbreviated… CISION PRNewswireOctober 30, 2025
Press Release AgiBot Robotics Debuted at IROS 2025, the AgiBot World Challenge Concluded Successfully SHANGHAI, Oct. 30, 2025 /PRNewswire/ — From October 19 to 25, 2025,… CISION PRNewswireOctober 30, 2025
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) The U.S. FDA approved STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) as interchangeable with the reference products… CISION PRNewswireOctober 30, 2025
